Depressive Symptoms and Metabolic Syndrome: Is Inflammation the Underlying Link?

Lucile Capuron, Shaoyong Su, Andrew H. Miller, J. Douglas Bremner, Jack Goldberg, Gerald J. Vogt, Carisa Maisano, Linda Jones, Nancy V. Murrah, Viola Vaccarino

Research output: Contribution to journalArticlepeer-review

165 Scopus citations


Background: Behavioral alterations, including depression, are frequent in individuals with the metabolic syndrome (MetS). Recent findings suggest that chronic activation of innate immunity might be involved. The objective of this study was to examine the relationship between MetS and depressive symptoms and to elucidate the involvement of inflammation in this relationship. Methods: Participants were 323 male twins, with and without MetS and free of symptomatic cardiovascular disease, drawn from the Vietnam Era Twin Registry. Depressive symptoms were measured with the Beck Depression Inventory (BDI). Inflammatory status was assessed using C-reactive protein (CRP) and interleukin-6 (IL-6); twins with both CRP and IL-6 levels above the median were classified as having an elevated inflammatory status. Factor analysis was performed on individual BDI items to extract specific symptom dimensions (neurovegetative, mood, affective-cognitive). Results: Subjects with MetS had more depressive symptoms than those without. Depressive symptoms with neurovegetative features were more common and more robustly associated with MetS. Both the BDI total score and each symptom subscore were associated with inflammatory biomarkers. After adjusting for age, education, and smoking status, the MetS was significantly associated with the BDI total score and the neurovegetative score. After further adjusting for inflammation, the coefficient for MetS decreased somewhat but remained statistically significant for the BDI neurovegetative subscore. When controlling for the MetS, inflammation remained significantly associated with the BDI mood subscore. Conclusions: The MetS is associated with higher depressive symptomatology characterized primarily by neurovegetative features. Inflammation is one determinant of depressive symptoms in individuals with MetS.

Original languageEnglish (US)
Pages (from-to)896-900
Number of pages5
JournalBiological Psychiatry
Issue number10
StatePublished - Nov 15 2008
Externally publishedYes


  • Cytokines
  • depression
  • inflammation
  • metabolic syndrome
  • mood

ASJC Scopus subject areas

  • Biological Psychiatry


Dive into the research topics of 'Depressive Symptoms and Metabolic Syndrome: Is Inflammation the Underlying Link?'. Together they form a unique fingerprint.

Cite this